Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population

Abstract

Objectives To study the management of pregnancy in multiple sclerosis (MS) patients on immunomodulatory therapy (IMT) in routine clinical practice and to analyze pregnancy outcomes and the clinical course of MS around pregnancy.

Methods Retrospective, multicentric study in Spain in MS patients receiving IMT before conception and followed for at least three months post-partum.

Results A total of 1286 medical records were reviewed. Eighty-eight pregnancies were identified in 74 (6%) women, 66% of which were unexposed and 34% exposed pregnancies. In most cases, IMT was discontinued before conception and resumed shortly after delivery. Accidental exposure to IMT did not lead to higher rates of abortions (P = 0.76) or malformations. The relapse rate was decreased during pregnancy (0.31 versus 0.61 in the pre-pregnancy year) and increased after delivery (0.87 on month 3), returning to pre-conception values on month 12. The median EDSS score was not increased during the study.

Conclusions Discontinuation of IMT before conception, and resumption shortly after delivery was the most frequent clinical practice procedure. Accidental exposure to IMT did not affect pregnancy outcomes or increased malformation rates. Pregnancy was associated with a reduced relapse rate. No factor was found to predict the risk of relapses during or after pregnancy. Multiple Sclerosis 2007; 13: 981—984. http://msj.sagepub.com

Keywords

accidental exposure disability immunomodulatory treatment pregnancy relapse rate

Get full access to this article

View all access options for this article.

References

Confavreux C. , Hutchinson M. , Hours MM , Cortinovis-Tourniare P. , Moreau T. Rate of pregnancy-related relapses in multiple scleoris. Pregnancy in multiple sclerosis study group . N Eng J Med 1998; 339: 285—91 .

Vukusic S. , Hutchinson M. , Hours M. , Moreau T. , Cortinovis-Tourniaire P. , Adeleine P. et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse . Brain 2004 ; 127: 1353—60 .

Mueller BA , Zhang J. , Critchlow CW Birth outcomes and need for hospitalization after delivery among women with mutliple sclerosis . Am J Obstet Gynecol 2002 ; 186: 446—52 .

NMSS Expert Opinion Paper. Disease managament consensus paper. National Multiple Sclerosis Society 2005; Available at: www.nationalmssociety.org/pdf/forpros/Exp_Consensus.pdf. Accessed 31 October 2006.

Ferrero S. , Pretta S. , Ragni N. Multiple sclerosis: management issues during pregnancy . Eur J Obstet Gynecol Reprod Biol 2004; 115: 3—9 .

Sandberg-Wollheim M. , Frank D. , Goodwin TM , Giesser B. , Lopez-Bresnahan M. , Stam-Moraga M. et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis . Neurology 2005; 65: 1—5 .

Coyle Pk , Johnson K. , Pardo L. , Stark Y. Pregnancy outcome in patients with multiple sclerosis treated with glatiramer acetate (Copaxone®) . ANN 2003 [abstract].

Boskovic R. , Wide R. , Woplin J. , Bauer DJ , Koren G. The reproductive effects of beta interferon therapy in pregnancy. A longitudinal cohort . Neurology 2005; 65: 807—11 .

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidlines for research protocols . Ann Neurol 1983; 13: 227—31 .

10.

Verdú Martín LI , Santamaría Lozano R. Aborto: Concepto y clasificación. Etiología, anatomía patológica, clínica y tratamiento. In Roura LC , director. Tratado de Ginecología, Obstetricia y Medicina de la Reproducción . Médica Panamericana , 2003.